Download Databook
Download Sample
NA : +1 804 441 9344
sales@towardshealthcare.com
Schedule a Meeting
July 2025
The global cryopreservation & platelet storage technologies market is on an upward trajectory, poised to generate substantial revenue growth, potentially climbing into the hundreds of millions over the forecast years from 2025 to 2034. This surge is attributed to evolving consumer preferences and technological advancements reshaping the industry.
The cryopreservation & platelet storage technologies market is rapidly expanding because increasing demand for blood components in diagnostics and healthcare. Growing surgical procedures, chronic diseases, and trauma cases are driving the demand for platelet storage. North America is dominant in the market due to advancements in cold chain infrastructure and increasing government investment in biotech. At the same time, Asia Pacific is the fastest-growing region due to advancements in portable devices and growing support from public health initiatives.
The cryopreservation & platelet storage technologies market refers to the collection of products, systems, and solutions used to preserve biological materials (cells, tissues, blood components, stem cells, reproductive cells, etc.) at ultra-low temperatures, and to safely store platelets at controlled temperatures and conditions. This market includes cryopreservation media, equipment (e.g., freezers, storage bags), additives (e.g., cryoprotectants like DMSO), and platelet storage devices aimed at extending shelf-life and preserving biological functionality for research, transfusion, fertility, regenerative medicine, and cell therapy applications. This cryopreservation extends the shelf life from 7 days to at least 2 years, although recent data suggest that platelet quality is maintained for up to 10 years.
AI integration in cryopreservation & platelet storage technologies is driving the growth of the market as AI-based cryopreservation monitoring is setting novel standards in the field, bringing round-the-clock vigilance and improving reliability and safety. This advancement in technology not only protects stored samples but also creates new opportunities in research and medicine, like fertility treatments. As AI technology continues to grow, its role in cryopreservation grows, accompanying an era of unprecedented safety and effectiveness for biobanking. AI-driven monitoring streamlines regulatory compliance and data management. Automated systems log all relevant data in real-time, offer a complete audit trail that streamlines compliance, and reduce the challenges of penalties. AI technology is supportive for detecting the ideal mediums to store biological material.
Increasing Application of Cryopreservation
The increase in cryopreservation stems from its role as a transformative technology that enables the long-term storage of biological materials by cooling them to extremely low temperatures, where metabolic and biochemical activities are significantly slowed or halted. Cryopreservation employs various techniques to prevent ice crystal formation and cellular damage during freezing and thawing. Its broad applications include medicine, agriculture, and conservation, covering areas such as stem cell research, reproductive and regenerative medicine, organ transplantation, and cell-based therapies. These applications have substantial economic impacts, driving growth in the cryopreservation & platelet storage technologies market.
High Cost Challenges
The high-performance demands and challenging operating environments of cryogenic heat exchangers result in elevated manufacturing and installation costs, which restrict the growth of the cryopreservation & platelet storage technologies market.
Advances in Platelet Preservation Incubator
Advances in platelet preservation and incubator systems aim to enhance storage conditions, boost efficiency, and minimize waste. The platelet incubator and agitator are engineered to maintain ideal storage environments, preserving platelet viability and function. Key features include a digital display, temperature regulation, and adjustable agitator speed. These products are gaining popularity for their outstanding performance and dependability. Many modern incubators also feature digital monitoring, temperature alarm systems, and remote management capabilities, opening new opportunities in the cryopreservation & platelet storage technologies market.
By product type, the cryopreservation equipment segment dominated in the cryopreservation & platelet storage technologies market in 2024 with a 28% share, as this equipment allows storing a wide range of disease-free biological samples for a long time. That preserves cells, organelles, tissues, or any other biological constructs by refrigeration the samples to very low temperatures. Incessant understanding of the physical and chemical characteristics that occur in the freezing and thawing cycle is necessary for the successful cryopreservation of cells or tissues and their medical applications.
The platelet storage systems segment is expected to grow at the fastest CAGR over the forecast period, 2025 to 2035, with a 14% CAGR, as these systems provide the accurate temperature uniformity, continuous agitation, and reliable performance that are significantly important to blood banks. Lower sound levels involve dropping noise in the laboratory, making a quieter workplace. It is designed and tested for the long-term reliability that is critically important for platelet storage. The advantages of this technique to the hospitals include a saving of time, a saving of blood, and avoiding the frantic efforts of blood bank and laboratory personnel to produce a huge number of fresh platelet concentrates at the time of platelet requirement.
By application, the biobanking segment is dominant in the cryopreservation & platelet storage technologies market in 2024, with a 22% share, as it provides priceless resources for investigating complex diseases, including diabetes, cancer, and cardiovascular disease. Biobanks are becoming significant in cultivating the objective of increasing population health by creating medicine efficient and customized for patients. Biobanks allow access to a large pool of high-quality human samples and related data. They are consistent hubs for the processing and storage of samples from clinical trials and different sources.
The blood & blood component preservation segment is expected to fastest-growing over the forecast period 2025 to 2035 with 16% CAGR, as it preserves the viability and function of every relevant constituent, prevents any physical variations of the blood constituent throughout storage, and diminishes bacterial growth. Whole blood and red cell concentrate should always be stored between 2 ͦ c and 6 ͦ c. A reduction in temperature less than 20 ͦ c causes freezing injury to the red cells, leading to haemolysis. If homolysed blood is transfused to a person, it leads to deadly consequences. It offers major advantages like long-term storage of rare blood groups and lower allergic and febrile transfusion reactions.
By end user, the biobanks & stem cell banks segment is dominant in the cryopreservation & platelet storage technologies market in 2024 with 41% share, as biobanks and stem cell banking provide the opportunity to valuable cells cryogenically frozen for over 25 years, ready for future use should they be essential. With their ability to grow into various types of blood and tissue cells, stem cells have the potential to protect and regenerate the body from within.
The hospitals & blood banks segment is expected to fastest-growing over the forecast period 2025 to 2035 with 13.5% CAGR, as blood banks in hospitals help other people to maintain good health or enable them to stay alive. It provides the benefits of blood donation for the donor. Blood banks gather blood and discrete it into its different components so they can be used most efficiently based on patients' requirements. RBCs carry oxygen, platelets help the blood clot, and plasma has particular proteins that allow appropriate regulation of coagulation and healing.
By storage technique, the vapor phase liquid nitrogen storage segment is dominant in the cryopreservation & platelet storage technologies market in 2024 with 46% share, as application of vapor phase nitrogen freezers protects researchers and provides simple access, but storage times are diminished. Vapor phase storage removes the challenges of evaporation and temperature control of liquid nitrogen, making the operation simpler and more suitable. Liquid nitrogen tanks are broadly used for storing organs and cells in the fields of biomedicine and the biotech industry.
The mechanical freezing segment is expected to fastest-growing over the forecast period 2025 to 2035 with 12% CAGR, as it helps to reduce relative moisture loss, enhance water holding capacity, minimize drip loss, reduce lipid oxidation, diminish colour change, and provide better preservation of microstructure. Mechanical freezing is presently more acceptable than ever for start-ups and novel production lines, due to its low running cost, rapid return on investment, and technological advantages.
By temperature range, the -150°C (Deep Cryogenic) segment is dominant in the Cryopreservation & Platelet Storage Technologies Market in 2024 with a 52% share, as it offers a consistent and stable temperature, lowering the challenges of ice crystal formation, which can damage cells and tissues. This technique also allows for long-term storage of biological samples, containing cells, tissues, and even embryos, with minimal degradation.
The 4°C to 24°C (for Platelets) segment is expected to fastest-growing over the forecast period 2025 to 2035 with 17% CAGR, as platelets stored at 4°C for 24 h have been shown to lower in vivo bleeding times by 40% compared to RT-stored platelets. It enhances hemostatic function, lowers bacterial contamination risks, and potentially longer shelf life.
By temperature range, the short-term platelet storage (5–7 Days) segment is dominant in the cryopreservation & platelet storage technologies market with 68% share, as this platelet storage is maintained for 7 days deprived of bacterial contamination, which would be an important step in growing the shelf life of platelets. Extending storage by a few days enables improved inventory management and lowers the need for frequent platelet processing and collection.
The extended platelet storage (7–14 Days) segment is expected to fastest-growing over the forecast period 2025 to 2035 with 18% CAGR as it offers numerous advantages, related to improved supply and reduced wastage. Extended storage alleviates platelet shortages, specifically for prophylactic use, and lowers transfusion expenses and the challenges of transfusion-related adverse events.
North America is dominant in the cryopreservation & platelet storage technologies market with the largest 48% share, as increasing pharmaceutical manufacturing in this region, growing investments in expanding blood bank infrastructure, driven by increasing demand for blood transfusions and pandemic preparedness, are driving the advancement of portable and compact blood refrigerators. Recent advancements in biobanking technology, like using Blockchain Technology (BCT) in the blood bank system, are to ensuring that the patient gets safe blood, which contributes to the growth of the market. The consistent increases in organ transplant demand in North America are driven by an aging population, augmented longevity, and higher rates of obesity associated with organ failure, which drives the growth of the market.
For instance,
In the United States, the blood supply for worldwide is safer than at any time in history. Because of development in donor screening, enhanced viral marker tests, changes in transfusion medicine practices, and automated data systems, the challenges associated with blood transfusion continue to decrease. The number of novel cancer cases generally goes up every year because the U.S. population is growing and aging ultimately improves the quality of care for cancer patients, which drives the demand for platelet transfusion, which increases the investment in platelet storage.
In Canada, the use of cryopreservation technology is due to the increasing demand for organ transplants. For instance, A total of 3,212 organ transplants were performed in Canada in 2024; 82% of transplants used dead donor organs and 18% used living donor organs. Growing access to significant clinical trial information and specimens would mainly enhance Canada’s biobanking volume in a way that would be sustainable due as most of the ‘soft infrastructure’ expenses would be covered by funding for clinical trials, driving the growth of the market.
The Asia Pacific region is projected to experience the fastest growth in the cryopreservation & platelet storage technologies market during the forecast period with 14–16% CAGR, with increasing population density, rising prevalence chronic disease, and growing surgical procedures, the demand for traceable, safe, and well-managed blood supply has grown continuously, this is major driver of the market. Governments and private healthcare providers are increasing spending in the digital transformation of healthcare, including the automation of blood banks, biobanks, and advanced cryopreservation technology.
For Instance,
The government of China actively supports biobank regulation due to its advanced research infrastructure, which is rapidly growing among Chinese hospitals. The innovation of China’s healthcare sector is progressively driven by the development of real-world data (RWD) and real-world evidence (RWE). Significant public and private investment in blood products' safety rushes advanced technology adoption, which drives the growth of the market.
India’s bio-science field has witnessed significant growth, and it holds huge potential for the country’s financial advancement and the well-being of its population. Increasing over 3,500 biotech startups and 2,500 biotech companies, India has recognized itself as a worldwide destination for biotechnology. These companies and startups are developing and commercializing next-gen storage systems, such as room temperature platelet bags with extended shelf life, which drives the growth of the market.
Europe is expected to grow significantly in the cryopreservation & platelet storage technologies market during the forecast period, as the European medical care sector will reorient to enhanced population and public health. Public health is becoming a government priority, converging on early primary care adoption to promote healthier lifestyles, which drives the market growth. Increasing innovation in organ preservation technology in Europe, such as automated controlled-rate freezers and eco-friendly solutions, contributes to the market growth.
For Instance,
In Germany increasing advancement in biobanks and blood bank solutions. Germany's biobanks are the source of significant materials in excellent innovative studies, providing pioneering researchers the opportunity to find novel treatments and enhance medical knowledge. It plays a significant role in healthcare research. This ensures that human biospecimens meet even standards of quality and that both the samples and their related data are simply accessible, which contributes to the growth of the market.
In May 2025, Dr. Parijat Jain, Vice President of Cell & Gene Therapy at BioIVT, stated, “BioIVT is committed to ongoing innovation by providing trusted, reproducible, and reliable experimental results to our partners through consistent cell populations. For clients needing GMP-compliant cellular starting materials but lacking the capacity or resources to incorporate fresh leukopaks into their development timelines, cryopreserved leukopaks offer the flexibility to plan and allocate resources for downstream processing of leukapheresis material. This approach helps meet client needs with our expanding portfolio.” (Source - Businesswire)
By Product Type
By Application
By End User
By Storage Technique
By Temperature Range
By Platelet Storage Type
By Region
July 2025
July 2025
July 2025
July 2025